ClinicalTrials.gg
Not yet recruitingNCT07933978Updated Nov 12, 2026

Online Mindfulness Intervention for Emotional Distress (MIED) in Adults With Emotional Eating

An interventional study of Mindfulness Intervention for Emotional Distress in Emotional Eating and Emotional Distress, sponsored by Xinghua Liu. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Xinghua Liu · Not applicable, Interventional, and Treatment

Updated Nov 12, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this randomized waitlist-controlled trial is to evaluate whether an online Mindfulness Intervention for Emotional Distress (MIED) can reduce self-reported emotional eating in Chinese adults. Emotional eating in this study refers to the urge or tendency to eat in response to negative emotions, such as anxiety, sadness, loneliness, or stress. The program teaches mindfulness and psychological skills for responding more flexibly to difficult emotions and urges.

The main questions this study aims to answer are:

Can online MIED reduce self-reported emotional eating compared with a waitlist control?

Can online MIED reduce anxiety and depressive symptoms and increase mindfulness?

The study will also examine course attendance, digital practice participation, acceptability, and adverse experiences.

An estimated 108 participants will be randomly assigned in equal numbers to receive online MIED immediately or to a waitlist control group. Researchers will compare questionnaire scores between the groups across the scheduled assessments. The waitlist group will be offered the same program after completion of the comparison follow-up assessments.

Participants will:

Complete eligibility screening, provide informed consent, and complete baseline assessments before random assignment.

Be randomly assigned to the intervention group or the waitlist group.

If assigned to intervention group, attend eight weekly online group sessions, approximately two hours each, and complete 49 days of self-help learning and practice through the iMIED WeChat mini-program, approximately 15-30 minutes daily.

Complete online questionnaires before the intervention, at Weeks 2 and 4, at program completion, and one month after the post-program assessment. Both groups will follow the same assessment schedule, referenced to the intervention group.

Provide feedback on participation, course experiences, and any adverse experiences. A subset of participants will be invited to interviews about their learning experiences and the relevance of the program to emotional eating.

02

Conditions studied

  • Emotional Eating
  • Emotional Distress

Browse trials for

Keywords

  • emotional eating
  • emotional distress
  • mindfulness intervention for emotional distress
03

In context

Emotional Eating

41 studies on the registry are indexed under Emotional Eating; 13 are open to participants now.

This study's planned enrollment of 108 is above the median of 72 across 34 interventional studies indexed under Emotional Eating.

Browse Emotional Eating studies →

Lead sponsor

Xinghua Liu is the lead sponsor of 7 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 65 years, inclusive.
  • Able to read Chinese and complete online study questionnaires.
  • A mean score of at least 2.8 on the Chinese 11-item DEBQ emotional eating subscale at eligibility screening, equivalent to a total score of at least 31 when all 11 items are completed.
  • Able to use a smartphone, WeChat, and the online group-session platform and to participate in the course and assessments.
  • Willing to participate voluntarily and provide before enrollment.

Exclusion criteria

Exclusion Criteria:

  • A self-reported history of schizophrenia, bipolar disorder, substance use disorder or another severe mental disorder diagnosed by a psychiatrist.
  • An explicit suicide plan, self-injurious behavior, or a psychological crisis requiring urgent intervention within the past month.
  • Initiation of psychiatric medication within the past three months, or a currently unstable psychiatric medication dosage.
  • Currently receiving structured psychotherapy or participating in another psychological intervention or weight-loss intervention program.
  • Serious medical or endocrine conditions, or pregnancy-related circumstances, that substantially affect eating or the ability to participate in the intervention.
  • A current diagnosis of an eating disorder, or severe eating-related problems involving physical health risks that require priority professional treatment.
  • Participation in a structured mindfulness-related course or intervention involving practice at least once per week within the past three months, including ongoing participation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (estimated)

Study arms

  • Experimental
    MIED

    Participants will receive eight weekly online MIED group sessions, approximately two hours per session, together with a 49-day iMIED self-help mindfulness course via WeChat mini-program. The intervention includes mindfulness practice and psychological education and is grounded in the psychopathological diamond model of emotional distress proposed by Liu and colleagues.

    Behavioral: Mindfulness Intervention for Emotional Distress

  • No intervention
    WL

    Participants will not receive mindfulness intervention during the comparison period. They will complete questionnaires on the same assessment schedule as the MIED group. After the one-month post-program comparison follow-up has been completed, they will be offered the same MIED group course and iMIED learning and practice program.

Interventions

  • BehavioralMindfulness Intervention for Emotional Distress

    A combined online group and digitally supported mindfulness program incorporating guided audio practice, educational materials, between-session exercises, reminders, and assistant support. The eight session themes are mindfulness and engagement in life; understanding emotions; sources of emotional distress and responses; distress tolerance; emotion-driven behaviors; cognitive flexibility; gradually approaching difficult situations; and maintaining practice after the course.

06

What researchers measure

Primary outcomes

  1. Chinese 11-Item DEBQ Emotional Eating Subscale

    Self-reported emotional eating will be assessed using the Chinese 11-item emotional eating subscale of the Dutch Eating Behavior Questionnaire (DEBQ-EE). Items are rated from 1 (lowest frequency) to 5 (highest frequency), using the validated Chinese response wording. The outcome score is the mean of the 11 item scores, ranging from 1 to 5; higher scores indicate more frequent negative emotion-related urges or tendencies to eat.

    Time frame: Baseline, 2 and 4 weeks after scheduled MIED program start, at the end of the 8-week MIED program (after the eighth scheduled session), and 1 month after scheduled program completion. Both groups follow the same schedule.

Secondary outcomes

  1. Overall Anxiety Severity and Impairment Scale (OASIS)

    The OASIS is a 5-item self-report measure designed to assess the frequency and severity of anxiety symptoms, as well as the extent of anxiety-related functional impairment and avoidance, over the past week. Each item is rated on a 5-point scale from 0 to 4, with total scores ranging from 0 to 20. Higher scores indicate greater overall anxiety severity and impairment. The OASIS has demonstrated good reliability and validity in both clinical and nonclinical samples (Norman et al., 2006).

    Time frame: Baseline, 2 and 4 weeks after scheduled MIED program start, at the end of the 8-week MIED program (after the eighth scheduled session), and 1 month after scheduled program completion. Both groups follow the same schedule.

  2. Overall Depression Severity and Impairment Scale (ODSIS)

    The ODSIS is a 5-item self-report measure designed to assess the frequency and severity of depressive symptoms, as well as depression-related functional impairment and avoidance, over the past week. Each item is rated on a 5-point scale from 0 to 4, with total scores ranging from 0 to 20. Higher scores indicate greater overall depression severity and impairment. The ODSIS has demonstrated good reliability and validity in both clinical and nonclinical samples (Bentley et al., 2014).

    Time frame: Baseline, 2 and 4 weeks after scheduled MIED program start, at the end of the 8-week MIED program (after the eighth scheduled session), and 1 month after scheduled program completion. Both groups follow the same schedule.

Other outcomes

  1. Chinese Short Form of the Five Facet Mindfulness Questionnaire

    Mindfulness will be assessed using the Chinese 20-item short form of the Five Facet Mindfulness Questionnaire (FFMQ-SF).

    Time frame: Baseline, 2 and 4 weeks after scheduled MIED program start, at the end of the 8-week MIED program (after the eighth scheduled session), and 1 month after scheduled program completion. Both groups follow the same schedule.

  2. Attendance at Online MIED Group Sessions

    Attendance will be summarized as the number of online MIED group sessions attended by each participant assigned to the intervention group

    Time frame: Attendance is recorded at each of the 8 scheduled online MIED group sessions. Sessions are held once weekly at a fixed time over 8 weeks, and each session lasts 120 minutes.

  3. Days of Digital Practice Recorded by the iMIED Platform

    Digital practice participation will be summarized as the number of days with a recorded practice activity during the 49-day iMIED program

    Time frame: Daily from Day 1 through Day 49 of the iMIED mini-program. Day 1 is the scheduled start date of the mini-program.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data (IPD) underlying the results reported in the main publication will be available upon reasonable request after publication of the primary trial results. The shared data will include deidentified participant-level data used in the primary and secondary analyses, including baseline characteristics, group allocation, outcome measures, follow-up assessments, adherence indicators, and safety outcomes. Directly or indirectly identifiable information will not be shared. Access will be provided to qualified researchers with a methodologically sound proposal, subject to approval by the principal investigator and relevant ethics requirements, and after completion of a data use agreement.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jan 2027, 2 months later.

Of 25 interventional studies with no phase under Emotional Eating, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 14. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 12, 2026
StartEst.
Nov 5, 2026
Primary completionEst.
Jan 20, 2027
CompletionEst.
Feb 20, 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07933978
Lead sponsor
Xinghua Liu
Responsible party
Xinghua Liu (Researcher, Peking University) — Sponsor-investigator
First posted
Nov 12, 2026
Start date
Nov 5, 2026 (estimated)
Primary completion
Jan 20, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

Jihong Tang, Master's degree
Contact
jhtang25@stu.pku.edu.cn
+86 13262532862

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion